EUVIMEDEUVIMED entdecken
Multizentrische StudieFall-Kontroll-StudieOpen Access · CC BY-NC-ND 4.0

Clinical characteristics and prognosis of bloodstream infections with carbapenem-resistant Gram-negative organisms in patients with hematological malignancies: A multicenter case-control study in China

Junxin Zhou, Jian Sun, Shanshan Lu, Xinhong Han, Jintao He, Ping Zhang, Huangdu Hu, Yuke Zhang, Yanfei Wang, Qin Yang, Shujuan Ji, Zhihui Zhou und 5 weitere

Journal of Infection · 2024-12 · 89 (6) · 106331

DOI: 10.1016/j.jinf.2024.106331 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Infection, 2024-12. Verfasst von Junxin Zhou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Microbial Te…. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Bacteremia, Carbapenems, Anti-Bacterial Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate clinical characteristics of hematological malignancy (HM) patients with carbapenem-resistant gram-negative organism (CRO) bloodstream infections (BSI) in China, and to elucidate the prognostic risk factors of CRO BSI. METHODS: We conducted a multicenter case-control study of 201 HM patients with CRO BSI between 2018-2020. Antimicrobial susceptibility testing and whole genome sequencing were performed for CRO isolates. Independent risk factors for 28-day crude mortality were analyzed using Cox proportional hazards regression models. The subgroups of major species were also evaluated. RESULTS: The pathogens responsible for CRO BSI in HM patients dominated by ST11 CRKP, ST167 CREC and ST463 CRPA. Most isolates produced carbapenemases with KPC and NDM being the main. CRO isolates had resistance rates to conventional antimicrobials ranging from 55%-100% and poor susceptibility to novel antimicrobials related to carbapenemases and species. The 28-day crude mortality was 24.2%. Non-Hodgkin lymphoma, heart disease, blaKPC-2 positive, empirical antibiotic therapy with linezolid, Pitt bacteremia score >3.5 were risk factors for 28-day mortality and appropriate definitive antibiotic therapy, tigecycline-containing therapy and aminoglycoside-containing therapy were protective factors. blaKPC-2 positive in CRKP and ST463 in CRPA were associated with Pitt bacteremia score >3.5. Solid tumor and other site infections before BSI were risk factors for ST463 CRPA BSI and pulmonary infection before BSI was risk factor for KPC-KP BSI. CONCLUSIONS: The antimicrobial resistance of CRO isolates for BSI in HM patients is critical. HM patients with CRO BSI should be treated with appropriate definitive antibiotic therapy based on early clarification of pathology and their antimicrobial susceptibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsBacteremiaCarbapenemsAnti-Bacterial AgentsHumansMaleCase-Control StudiesFemaleChinaMiddle AgedAgedPrognosisAdultRisk FactorsGram-Negative BacteriaGram-Negative Bacterial InfectionsMicrobial Sensitivity Testsbeta-Lactamases

Stichwörter der Autor:innen

Bloodstream infectionCarbapenem-resistant Gram-negative organismHematological malignancyRisk factor

Substanzen

CarbapenemsAnti-Bacterial Agentsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China; Reg…
  • Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • Centre of Laboratory Medicine, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
  • Department of Infectious Diseases, Centre for General Practice Medicine, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Förderung

  • Medical Science and Technology Project of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Innovative Research Group Project of the National Natural Science Foundation of China

Zitieren

APA

Zhou, J., Sun, J., Lu, S., Han, X., He, J., Zhang, P., Hu, H., Zhang, Y., Wang, Y., Yang, Q., Ji, S., Zhou, Z., Hua, X., Wu, X., Jiang, Y., Du, X., & Yu, Y. (2024). Clinical characteristics and prognosis of bloodstream infections with carbapenem-resistant Gram-negative organisms in patients with hematological malignancies: A multicenter case-control study in China. Journal of Infection, 89(6), 106331. https://doi.org/10.1016/j.jinf.2024.106331

Vancouver

Zhou J, Sun J, Lu S, Han X, He J, Zhang P, et al. Clinical characteristics and prognosis of bloodstream infections with carbapenem-resistant Gram-negative organisms in patients with hematological malignancies: A multicenter case-control study in China. Journal of Infection. 2024;89(6):106331. doi:10.1016/j.jinf.2024.106331

BibTeX
@article{Zhou2024,
  author = {Zhou, Junxin and Sun, Jian and Lu, Shanshan and Han, Xinhong and He, Jintao and Zhang, Ping and Hu, Huangdu and Zhang, Yuke and Wang, Yanfei and Yang, Qin and Ji, Shujuan and Zhou, Zhihui and Hua, Xiaoting and Wu, Xueqing and Jiang, Yan and Du, Xiaoxing and Yu, Yunsong},
  title = {Clinical characteristics and prognosis of bloodstream infections with carbapenem-resistant Gram-negative organisms in patients with hematological malignancies: A multicenter case-control study in China},
  journal = {Journal of Infection},
  year = {2024},
  volume = {89},
  number = {6},
  pages = {106331},
  doi = {10.1016/j.jinf.2024.106331}
}
Kostenlos starten →